Johnson & Johnson
JNJ
#23
Rank
$650.673 B
Marketcap
United States
Country
$270.00
Share price
3.93%
Change (1 day)
53.47%
Change (1 year)
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and…
Key Metrics
Trailing P/E
31.31
Forward P/E
22.00
EPS (TTM)
$8.63
Forward EPS
$12.29
Price / Book
7.66
EV / EBITDA
19.3x
Beta
0.23
Dividend Yield
2.01%
Return on Equity
25.74%
Return on Assets
8.60%
Debt / Equity
57.71
Current Ratio
1.09
Gross Margin
68.14%
Operating Margin
29.19%
Net Profit Margin
21.48%
Free Cash Flow
$16.885B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 18 – Sep 17
-0.33%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$94.193B
Latest Net Income$26.804B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Johnson & Johnson with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
JNJ
No recent news available. Set FINNHUB_API_KEY to enable news.
